Editas Medicine, Inc. (0IFK.L)
USD 0.97
(-7.8%)
USD 0.97
(-7.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 78.12 Million | 19.71 Million | 25.54 Million | 90.73 Million | 20.53 Million | 31.93 Million |
| Cost of Revenue | 177.65 Million | 6.33 Million | 5.05 Million | 157.99 Million | 96.89 Million | 90.65 Million |
| Gross Profit | -99.52 Million | 13.37 Million | 20.49 Million | -67.26 Million | -76.36 Million | -58.71 Million |
| Operating Expenses | 247.3 Million | 245.66 Million | 218.69 Million | 225.57 Million | 161.45 Million | 145.66 Million |
| Selling, General and Administrative Expenses | 69.65 Million | 70.7 Million | 76.18 Million | 67.57 Million | 64.55 Million | 55.01 Million |
| Research and Development Expenses | 177.65 Million | 174.95 Million | 142.5 Million | 157.99 Million | 96.89 Million | 90.65 Million |
| Other Expenses | - | 1.29 Million | -1.69 Million | 16.25 Million | -137 Thousand | 328 Thousand |
| Cost and Expenses | 247.3 Million | 245.66 Million | 218.69 Million | 225.57 Million | 161.45 Million | 145.66 Million |
| Operating Income | -169.18 Million | -225.95 Million | -193.14 Million | -134.84 Million | -140.92 Million | -113.72 Million |
| Interest Expense | - | 4.22 Million | - | - | - | - |
| Income Tax Expense | - | -16.08 Million | -7.39 Million | -6.56 Million | -10.28 Million | -3.11 Million |
| Earnings before Tax | -153.21 Million | -220.43 Million | -192.5 Million | -115.97 Million | -133.74 Million | -109.95 Million |
| Net Income | -153.21 Million | -204.35 Million | -185.1 Million | -109.41 Million | -123.46 Million | -109.95 Million |
| Earnings Per Share Basic | -2.02 | -2.98 | -2.74 | -1.87 | -2.47 | -2.33 |
| Earnings Per Share Diluted | -2.02 | -2.98 | -2.74 | -1.87 | -2.47 | -2.33 |
| Weighted Average Shares Outstanding | 75.96 Million | 68.66 Million | 67.61 Million | 58.6 Million | 49.98 Million | 47.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.96 Million | 68.66 Million | 67.61 Million | 58.6 Million | 49.98 Million | 47.09 Million |
| Gross Margin | -1.27 | 0.68 | 0.80 | -0.74 | -3.72 | -1.84 |
| EBIT Margin | -2.09 | -11.46 | -7.56 | -1.49 | -6.87 | -3.55 |
| Profit Margin | -1.96 | -10.37 | -7.25 | -1.21 | -6.01 | -3.44 |
| EBITDA | -163.11 Million | -219.61 Million | -188.09 Million | -130.88 Million | -138.09 Million | -110.47 Million |
| Earnings Before Tax Margin | -2.17 | -11.46 | -7.56 | -1.49 | -6.86 | -3.56 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 61 Thousand | 513 Thousand | 1.13 Million | 78.12 Million | 60.04 Million | 5.33 Million |
| Cost of Revenue | 1.59 Million | 1.42 Million | 1.4 Million | 6.06 Million | 1.46 Million | 1.51 Million |
| Gross Profit | -1.53 Million | -907 Thousand | -274 Thousand | 72.05 Million | 58.58 Million | 3.82 Million |
| Operating Expenses | 65.72 Million | 70.99 Million | 66.71 Million | 241.24 Million | 82.54 Million | 55.49 Million |
| Selling, General and Administrative Expenses | 18.08 Million | 18.2 Million | 19.33 Million | - | 14.45 Million | 14.98 Million |
| Research and Development Expenses | 61 Thousand | 52.79 Million | 47.37 Million | - | 68.09 Million | 5.33 Million |
| Other Expenses | 47.57 Million | -1000.00 | 6000.00 | -1.6 Million | -14 Thousand | 35.17 Million |
| Cost and Expenses | 65.72 Million | 72.41 Million | 68.12 Million | 247.3 Million | 84.01 Million | 55.49 Million |
| Operating Income | -62.14 Million | -71.9 Million | -66.99 Million | -169.18 Million | -23.96 Million | -45.01 Million |
| Interest Expense | - | - | - | - | 3.46 Million | - |
| Income Tax Expense | 1.92 Million | - | 1.00 | 5.89 Million | 10.33 Million | -1.51 Million |
| Earnings before Tax | -62.14 Million | -67.6 Million | -61.95 Million | -153.21 Million | -18.87 Million | -45.01 Million |
| Net Income | -62.14 Million | -67.6 Million | -61.95 Million | -153.21 Million | -18.87 Million | -45.01 Million |
| Earnings Per Share Basic | -0.75 | -0.82 | -0.76 | - | -0.23 | -0.55 |
| Earnings Per Share Diluted | -0.75 | -0.82 | -0.76 | - | -0.23 | -0.55 |
| Weighted Average Shares Outstanding | 82.48 Million | 82.31 Million | 81.93 Million | 75.96 Million | 81.71 Million | 81.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.48 Million | 82.31 Million | 81.93 Million | 75.96 Million | 81.71 Million | 81.64 Million |
| Gross Margin | -25.21 | -1.77 | -0.24 | 0.92 | 0.98 | 0.72 |
| EBIT Margin | -1018.70 | -137.39 | -57.78 | - | -0.37 | -8.44 |
| Profit Margin | -1018.70 | -131.79 | -54.58 | -1.96 | -0.31 | -8.44 |
| EBITDA | -62.14 Million | -70.48 Million | -65.58 Million | - | -22.49 Million | -45.01 Million |
| Earnings Before Tax Margin | -1018.70 | -140.16 | -59.02 | -2.17 | -0.40 | -8.44 |
PUBC
OAK
NBBK
KEQU
OSBK
2726